These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 36986545)

  • 1. The In Vitro Anti-Parasitic Activities of Emodin toward
    Adeyemi OS; Ishii K; Kato K
    Pharmaceuticals (Basel); 2023 Mar; 16(3):. PubMed ID: 36986545
    [TBL] [Abstract][Full Text] [Related]  

  • 2. L-tryptophan-titanium oxide nanoparticles showed selective anti-Toxoplasma gondii activity and improved host biocompatibility.
    Adeyemi OS; Ishii K; Kato K
    Biomed Pharmacother; 2023 Jun; 162():114597. PubMed ID: 36989712
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In vitro anti-Toxoplasma gondii efficacy of synthesised benzyltriazole derivatives.
    Guo H; Gao Y; N'Da DD; Xuan X
    Onderstepoort J Vet Res; 2021 Jun; 88(1):e1-e8. PubMed ID: 34212734
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhibition of
    Huffman AM; Ayariga JA; Napier A; Robertson BK; Abugri DA
    Front Cell Infect Microbiol; 2022; 12():852889. PubMed ID: 35646733
    [No Abstract]   [Full Text] [Related]  

  • 5. The anti-parasite action of imidazole derivatives likely involves oxidative stress but not HIF-1α signaling.
    Adeyemi OS; Eseola AO; Plass W; Kato K; Otuechere CA; Awakan OJ; Atolani O; Otohinoyi DA; Elebiyo TC; Evbuomwan IO
    Chem Biol Interact; 2021 Nov; 349():109676. PubMed ID: 34592218
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Impact of Engineered Expression of Mitochondrial Association Factor 1b on
    English ED; Boyle JP
    mSphere; 2018 Oct; 3(5):. PubMed ID: 30333181
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Discovery of New Inhibitors of Toxoplasma gondii via the Pathogen Box.
    Spalenka J; Escotte-Binet S; Bakiri A; Hubert J; Renault JH; Velard F; Duchateau S; Aubert D; Huguenin A; Villena I
    Antimicrob Agents Chemother; 2018 Feb; 62(2):. PubMed ID: 29133550
    [No Abstract]   [Full Text] [Related]  

  • 8. New life for an old drug: In vitro and in vivo effects of the anthelmintic drug niclosamide against Toxoplasma gondii RH strain.
    Zhang JL; Si HF; Shang XF; Zhang XK; Li B; Zhou XZ; Zhang JY
    Int J Parasitol Drugs Drug Resist; 2019 Apr; 9():27-34. PubMed ID: 30599391
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Phytoecdysteroids as modulators of the Toxoplasma gondii growth rate in human and mouse cells.
    Dzitko K; Grzybowski MM; Pawełczyk J; Dziadek B; Gatkowska J; Stączek P; Długońska H
    Parasit Vectors; 2015 Aug; 8():422. PubMed ID: 26272689
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Promising
    Esboei BR; Keighobadi M; Hezarjaribi HZ; Fakhar M; Daryani A; Chabra A; Soosaraei M; Yalveh R
    Infect Disord Drug Targets; 2021; 21(1):151-155. PubMed ID: 32389115
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In vitro activity of the interaction between taxifolin (dihydroquercetin) and pyrimethamine against Toxoplasma gondii.
    Abugri DA; Witola WH; Russell AE; Troy RM
    Chem Biol Drug Des; 2018 Jan; 91(1):194-201. PubMed ID: 28696589
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Exploring Amino Acid-Capped Nanoparticles for Selective Anti-Parasitic Action and Improved Host Biocompatibility.
    Adeyemi OS; Murata Y; Sugi T; Han Y; Kato K
    J Biomed Nanotechnol; 2018 May; 14(5):847-867. PubMed ID: 29883557
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lectins from
    ; Ramos EL; Santana SS; Silva MV; Santiago FM; Mineo TW; Mineo JR
    Front Cell Infect Microbiol; 2016; 6():164. PubMed ID: 27933277
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Human toxoplasmosis-Searching for novel chemotherapeutics.
    Antczak M; Dzitko K; Długońska H
    Biomed Pharmacother; 2016 Aug; 82():677-84. PubMed ID: 27470411
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Synthesis, in vitro and in vivo biological evaluation of dihydroartemisinin derivatives with potential anti-Toxoplasma gondii agents.
    Deng H; Huang X; Jin C; Jin CM; Quan ZS
    Bioorg Chem; 2020 Jan; 94():103467. PubMed ID: 31791681
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Modulation of host HIF-1α activity and the tryptophan pathway contributes to the anti-
    Adeyemi OS; Murata Y; Sugi T; Han Y; Kato K
    Biochem Biophys Rep; 2017 Sep; 11():84-92. PubMed ID: 28955772
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The P2X7 Receptor Mediates
    Moreira-Souza ACA; Almeida-da-Silva CLC; Rangel TP; Rocha GDC; Bellio M; Zamboni DS; Vommaro RC; Coutinho-Silva R
    Front Immunol; 2017; 8():1257. PubMed ID: 29075257
    [No Abstract]   [Full Text] [Related]  

  • 18. Licochalcone A: An effective and low-toxicity compound against Toxoplasma gondii in vitro and in vivo.
    Si H; Xu C; Zhang J; Zhang X; Li B; Zhou X; Zhang J
    Int J Parasitol Drugs Drug Resist; 2018 Aug; 8(2):238-245. PubMed ID: 29684680
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Drug Repurposing Based on Protozoan Proteome: In Vitro Evaluation of In Silico Screened Compounds against
    Cajazeiro DC; Toledo PPM; de Sousa NF; Scotti MT; Reimão JQ
    Pharmaceutics; 2022 Aug; 14(8):. PubMed ID: 36015260
    [No Abstract]   [Full Text] [Related]  

  • 20. Nanomedicine advances in toxoplasmosis: diagnostic, treatment, and vaccine applications.
    Assolini JP; Concato VM; Gonçalves MD; Carloto ACM; Conchon-Costa I; Pavanelli WR; Melanda FN; Costa IN
    Parasitol Res; 2017 Jun; 116(6):1603-1615. PubMed ID: 28477099
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.